The company is focused on developing spinal fusion products for treating degenerative disc disease. The company was able to experience success, despite an 8 percent decline in the number of spinal fusions for DDD performed in the United States.
Related Articles on Spine Devices:
26 Spine Devices Receive FDA 510(k) Clearance in December
5 Spine-Driven Device Company Financial Reports
14 Spine Device Company Executive Moves
UAMS’ AI playbook for capacity lift & fewer cancellations
Recommended Live Webinar on Jan 21, 2026 1:00 PM - 2:00 PM CST